Company Profile
- Stock Code
- GH
- ISIN Code
- US40131M1099
- Currency
- US Dollar (USD)
- IPO Date
- 2018-10-04

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a...